← Back to Clinical Trials
Recruiting NCT06106984

NCT06106984 Home-based Rehabilitation Intervention for Phantom Limb Pain in Veterans With Lower Limb Amputations

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06106984
Status Recruiting
Phase
Sponsor VA Office of Research and Development
Condition Phantom Limb Pain
Study Type INTERVENTIONAL
Enrollment 36 participants
Start Date 2024-04-01
Primary Completion 2028-11-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 89 Years
Study Type INTERVENTIONAL
Interventions
Graded motor imagery mobile app

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 36 participants in total. It began in 2024-04-01 with a primary completion date of 2028-11-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Nearly 60-85% of Veterans with amputations experience pain at the location of the amputated limb called phantom limb pain (PLP). PLP is a major problem and can have a profound impact on Veteran's daily function and ability to fully participate in life. Although several rehabilitation interventions are promising, advances in novel rehabilitation interventions are limited. The objective of this project is to refine a mobile app for graded motor imagery in 12 Veterans with amputations and test the mobile app with 36 Veterans with amputations. For this pilot project, the investigators will measure the preliminary feasibility and acceptability of the intervention. Knowledge from this project will provide evidence to guide future larger studies of this graded motor imagery intervention. Developing novel strategies for chronic pain in this population will positively impact quality of life for Veterans with amputations.

Eligibility Criteria

Inclusion Criteria: * Must be a military Veteran * At least 18 years old; * \>1 year since unilateral below knee amputation; * Moderate or severe (NRS score 4 on a 0-10 scale) PLP; * Stable medications over the past 2 weeks; * Willing and able to give informed consent; and * Able to participate in the telehealth study activities with a personal device. Exclusion Criteria: * Unstable medical conditions (e.g., uncontrolled diabetes, heart failure exacerbation); * Unstable mental illness or substance use disorder (e.g., active suicidality or psychosis); and * Unable to give informed consent due to a cognitive impairment. * Fibromyalgia or complex regional pain syndrome-like symptoms

Contact & Investigator

Central Contact

Tonya L Rich, PhD MA BS

✉ Tonya.Rich@va.gov

📞 (612) 467-5463

Principal Investigator

Tonya L Rich, PhD MA BS

PRINCIPAL INVESTIGATOR

Minneapolis VA Health Care System, Minneapolis, MN

Frequently Asked Questions

Who can join the NCT06106984 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 89 Years, studying Phantom Limb Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06106984 currently recruiting?

Yes, NCT06106984 is actively recruiting participants. Contact the research team at Tonya.Rich@va.gov for enrollment information.

Where is the NCT06106984 trial being conducted?

This trial is being conducted at Minneapolis, United States.

Who is sponsoring the NCT06106984 clinical trial?

NCT06106984 is sponsored by VA Office of Research and Development. The principal investigator is Tonya L Rich, PhD MA BS at Minneapolis VA Health Care System, Minneapolis, MN. The trial plans to enroll 36 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology